Microbot Medical Inc. (MBOT) Institutional Ownership

Ownership Summary

Microbot Medical Inc. (NASDAQ:MBOT) currently has 15 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• These investors collectively held 15.5% of the company's total shares outstanding in December 2025, down from 39.0% in September 2025.
• Quarterly data indicates a 58.13% shift in institutional share volume, and the annual owner count reflects a decrease of 61.54%.
• Of these 15 institutional investors, 4 increased their holdings in Microbot Medical, while 3 of them reduced positions, and 8 investors maintained their exposure.
• The aggregate institutional position in Microbot Medical now stands at 4.52Mn shares as of December 2025, after investors increased their holdings (up by 1.66Mn shares quarter on quarter which is up 3.41Mn shares year over year).
• The top institutional stake in Microbot Medical as of December 31, 2025 belongs to VANGUARD GROUP INC, which owns 3.33Mn shares, or 11.46% of the company.
• Among the most significant buyers of Microbot Medical during December 2025 were VANGUARD GROUP INC (986.16K), DnB Asset Management AS (433.87K), UBS Group AG (242.29K), Avion Wealth (500).
• Leading sellers of Microbot Medical stock in December 2025 included U.S. Capital Wealth Advisors, LLC (1.30K), SBI Securities Co., Ltd. (940), LEE DANNER & BASS INC (386).
• The top 10 institutional holders of Microbot Medical for the quarter ending December 2025 included VANGUARD GROUP INC (3.33Mn), DnB Asset Management AS (677.50K), UBS Group AG (445.13K), LAZARI CAPITAL MANAGEMENT, INC. (21.25K), LEE DANNER & BASS INC (10.25K), U.S. Capital Wealth Advisors, LLC (10.00K), Cornerstone Advisory, LLC (10.00K), BFSG, LLC (5.50K), CWM, LLC (2.75K), SBI Securities Co., Ltd. (2.63K).